@FierceMedDev: CareFusion has staged a Class I recall of some of its infant breathing devices. Item | Follow @FierceMedDev
@MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce
@DamianFierce: Roche continues to expand its diagnostics business with an FDA nod for a new HIV test. Story | Follow @DamianFierce
> The FDA is proposing every medical device marketed in the U.S. feature a unique ID tag, looking to improve reporting of adverse events and device safety. The agency will seek comment on the proposal for 120 days. Statement
> W.L. Gore has received a CE mark for expanded sizes of its Excluder AAA endoprosthesis, a device designed to treat abdominal aortic aneurysm. More
> Researchers at Northwestern University have developed electronics that can stretch to more than 200% their original size, a development that could lead to super-flexible medical devices. Article
> Syneron Medical ($ELOS) has received FDA clearance for its Elos Plus system, a multi-platform dermatological tech used in aesthetic procedures. The device is already available in Europe and Asia. News
> ProPep Surgical received 510(k) clearance for its nerve monitoring system, an intraoperative tech designed to accompany robotic prostate cancer surgery. Release
Pharma News
@FiercePharma: Jefferies analysts like India's Cipla, Ranbaxy, Sun Pharma, because of emerging markets sales. Item | Follow @FiercePharma
> Will Amylin buy favor AZ's Simon Lowth in CEO contest? More
> Purdue aims to extend OxyContin monopoly with test in kids. Article
> Icahn looks askance at Forest CEO's stock trading. Story
Biotech News
@FierceBiotech: Researchers shatter record with U.S.-China genomic data transfer. News | Follow @FierceBiotech
@JohnCFierce: Rodman's Michael King says 'whoops' on Amylin, believes Vivus and MannKind (huh?) next likely diabetes targets. Item | Follow @JohnCFierce
@RyanMFierce: A good job rounding up the early-stage biotech VC usual suspects. More | Follow @RyanMFierce
> GlobeImmune's $69M IPO designed to build immunotherapy pipeline. Article
> In R&D showdown, Genentech beat Roche in a TKO. Story
> J&J rushes drug-resistant TB therapy bedaquiline to FDA. News
Biotech Research News
> Promising mouse study lays foundation for startup's autism drug program. Article
> In breakthrough, stem cell transplants reverse diabetes in mice. Story
> Texas cancer research funding effort may shift to startups. Item
> Mayo Clinic researchers find novel way to repair MS damage. News
Pharma Manufacturing News
> GlaxoSmithKline's Witty says manufacturing must become more efficient. More
> J&J recalls 69,000 units of K-Y vaginal lubricant. News
> United snags Glaxo buildings as it completes expansion. Story
> ScinoPharm building new cancer injectables plant in China. Article
Biomarkers News
> Marker helps docs pick kids' bone cancer treatment. Story
> Developing proteomic signatures focus pancreatic cancer therapy. Article
> Heart size distorts biomarker levels. More
> Apolipoproteins mark diabetic visual loss. Item
> Biomarkers spot hep C liver disease. Story